General Information of the Protein
| Protein ID |
PT03632
|
||||
|---|---|---|---|---|---|
| Protein Name |
Sigma intracellular receptor 2
|
||||
| Secondarily Protein Name |
Meningioma-associated protein 30
Transmembrane protein 97
|
||||
| Gene Name |
TMEM97
|
||||
| Secondarily Gene Name |
MAC30
S2R
|
||||
| Sequence |
MGAPATRRCVEWLLGLYFLSHIPITLFMDLQAVLPRELYPVEFRNLLKWYAKEFKDPLLQEPPAWFKSFLFCELVFQLPFFPIATYAFLKGSCKWIRTPAIIYSVHTMTTLIPILSTFLFEDFSKASGFKGQRPETLHERLTLVSVYAPYLLIPFILLIFMLRSPYYKYEEKRKKK
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Membrane receptor
|
||||
| Function |
Intracellular sigma-2 receptor that binds histatin 1/HN1 (Hst 1) at the endoplasmic reticulun (ER) membrane, which is critical for mitochondrial-targeting and -activating properties of Hst1 (PubMed:34233061, PubMed:35970844). Thought to play important role in regulating cell survival, morphology and differentiation (PubMed:23922215, PubMed:25620095). May play a role as a regulator of cellular cholesterol homeostasis (PubMed:19583955). May function as sterol isomerase (PubMed:25566323). May alter the activity of some cytochrome P450 proteins (PubMed:22292588).
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Nucleus membrane
Rough endoplasmic reticulum membrane
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000001 , Jurkat
Cell Line ID: CL000996 , RT-4
Cell Line ID: CL000013 , Sf9
Biochemical Assays
| Compound ID | Compound Name | Compound Formula | |
| CP0013421 |
CAS_97-39-2
Show/Hide
|
C15H17N3
|
2 |
| 1 | Ki = 18 nM | ||
|---|---|---|---|
| 2 | Ki = 28.4 nM | ||
Clinical Information about the Protein
Target 1 ( Sigma intracellular receptor 2 (TMEM97) )
| Target Type | Clinical trial Target | ||||
|---|---|---|---|---|---|
| Disease | 1 Target-related Disease | 1 | |||
| 1 | Alzheimer disease [ICD-11: 8A20] | ||||
| Clinical Trial Drug(s) | 1 Clinical Trial Drug | 1 | |||
| 1 | CT1812 | Phase 2 | |||
Target 2 ( HUMAN sigma intracellular receptor 2 (TMEM97) )
| Target Type | Unknown Type Target | ||||
|---|---|---|---|---|---|
| Disease | 2 Target-related Diseases | 2 | |||
| 1 | Schizophrenia [ICD-11: 6A20] | ||||
| 2 | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | ||||
| Investigative Drug(s) | 2 Investigative Drugs | 2 | |||
| 1 | Haloperidol | Approved | |||
| 2 | PB28 | Investigative | |||